Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-14141094112023-03-142022-05-160trueNo description of principal activitytrue6true 14109411 2022-05-15 14109411 2022-05-16 2023-03-14 14109411 2021-04-01 2022-05-15 14109411 2023-03-14 14109411 1 2022-05-16 2023-03-14 14109411 d:Director7 2022-05-16 2023-03-14 14109411 c:ShareCapital 2023-03-14 14109411 c:RetainedEarningsAccumulatedLosses 2022-05-16 2023-03-14 14109411 d:OrdinaryShareClass1 2022-05-16 2023-03-14 14109411 d:OrdinaryShareClass1 2023-03-14 14109411 d:OrdinaryShareClass2 2022-05-16 2023-03-14 14109411 d:OrdinaryShareClass2 2023-03-14 14109411 d:OrdinaryShareClass3 2022-05-16 2023-03-14 14109411 d:OrdinaryShareClass3 2023-03-14 14109411 d:EntityHasNeverTraded 2022-05-16 2023-03-14 14109411 d:FRS102 2022-05-16 2023-03-14 14109411 d:AuditExempt-NoAccountantsReport 2022-05-16 2023-03-14 14109411 d:FullAccounts 2022-05-16 2023-03-14 14109411 d:PrivateLimitedCompanyLtd 2022-05-16 2023-03-14 14109411 c:Subsidiary1 2022-05-16 2023-03-14 14109411 c:Subsidiary1 1 2022-05-16 2023-03-14 14109411 c:Subsidiary2 2022-05-16 2023-03-14 14109411 c:Subsidiary2 1 2022-05-16 2023-03-14 14109411 6 2022-05-16 2023-03-14 xbrli:shares iso4217:GBP xbrli:pure



















HubRx Holdings Limited

Registered number: 14109411
Information for filing with the Registrar
For the period ended 14 March 2023

 
 14109411
14 March 2023
HUBRX HOLDINGS LIMITED
REGISTERED NUMBER: 14109411

STATEMENT OF FINANCIAL POSITION
AS AT 14 MARCH 2023

2023
Note
£

Fixed assets
  

Investments
 4 
1,000

  
1,000

  

  

Net assets
  
1,000


Capital and reserves
  

Called up share capital 
 5 
1,000

  
1,000


For the period ended 14 March 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 March 2024.




M T Tollefson
Director

The notes on pages 2 to 4 form part of these financial statements.

- 1 -

 
 14109411
14 March 2023
HUBRX HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 14 MARCH 2023

1.


General information

HubRx Holdings Limited is a private company limited by shares incorporated in the United Kingdom. The company's registered number is 14109411. The address of its registered office is Unit 7, Logic Park, Skelton Moor Way, Halton, Leeds, United Kingdom, LS15 OBF. 
The principal activity of the Company is that of a holding company. 
The financial statements have been presented in Pound Sterling as this currency of the primary economic environment in which the Company operates and is rounded to the nearest pound. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

 
2.2

Going concern

To the best of my knowledge there is nothing to indicate that the Company will not continue as a going concern. Whilst the Company is not expected to trade in the coming year, the directors do not intend to wind up the Company, it will remain dormant for the foreseeable future. The period to which the directors have paid particular attention in assessing the appropriateness of the going concern basis is not less than twelve months from the date of approval of the accounts.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.


3.


Employees

The average monthly number of employees, including the directors, during the period was as follows:


   9 months ended
       14 March
        2023
            No.






Directors
6

- 2 -

 
 14109411
14 March 2023
HUBRX HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 14 MARCH 2023

4.


Fixed asset investments





Investments in subsidiary companies

£



Cost and net book value


Additions
1,000



At 14 March 2023
1,000





Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

HubRx Ltd
Unit 7 Logic Park, Skelton Moor Way, Leeds, England, LS15 OBF
Ordinary
100%
Pharmacy Plus Health Limited*
Unit 7 Logic Park, Skelton Moor Way, Leeds, England, LS15 OBF
Ordinary
100%

*Pharmacy Plus Health Limited is wholly owned by HubRx Ltd.


5.


Share capital

2023
£
Allotted, called up and fully paid


400 Ordinary A shares of £1.00 each
400
200 Ordinary B shares of £1.00 each
200
400 Ordinary C shares of £1.00 each
400

1,000


All shares rank pari passu in all respects.


6.


Reserves

Profit and loss account

This reserve represents the cumulative profits and losses, less dividends. 

- 3 -

 
 14109411
14 March 2023
HUBRX HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 14 MARCH 2023

7.


Post balance sheet events

Following the period end, the subsidiary company, Pharmacy Plus Health Limited, acquired a group of companies in order to fulfil the activities of the Group in future periods.


8.


Controlling party

The directors do not consider there to be one single ultimate controlling party. 

- 4 -